Patent Assignment
Reel/Frame 075099/0441
Patent Security Agreement
Recorded: 2026-03-16
Received: 2026-03-16
Pages: 20
Assignor
RADIUS PHARMACEUTICALS, INC.
Executed: 2026-03-16
Assignee
WILMINGTON TRUST, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT
50 SOUTH SIXTH STREET, SUITE 1290, MINNEAPOLIS, MN, 55402, UNITED STATES
Covered Properties
(24)
Elacestrant in Combination with Abemaciclib in Women with Breast Cancer
Application:
19/338,117 →
Processes and Compounds
Application:
19/324,847 →
Methods for Treating Cancer
Application:
19/302,585 →
Methods for Treating Cancer
Application:
19/297,614 →
Polymorphic Forms of RAD1901-2HCL
Application:
19/283,114 →
Methods for Treating Cancer Resistant to CDK4/6 Inhibitors
Application:
19/250,779 →
Estrogen Receptor-Modulating Compounds
Application:
18/661,960 →
Polymorphic Forms of RAD1901-2HCL
Application:
18/203,678 →
Methods for Treating Cancer
Application:
17/852,673 →
Estrogen Receptor-Modulating Compounds
Application:
17/828,832 →
Estrogen Receptor-Modulating Compounds
Application:
17/629,041 →
Treating Y537S Mutant Breast Cancer with RAD1901 and mTOR inhibitor
Application:
17/510,050 →
Polymorphic Forms of RAD1901-2HCL
Application:
17/475,018 →
Processes and Compounds
Application:
17/430,248 →
Polymorphic Forms of RAD1901-2HCL
Application:
17/257,372 →
Methods for Treating Cancer
Application:
16/985,021 →
Estrogen Receptor-Modulating Compounds
Application:
16/963,794 →
Polymorphic Forms of RAD1901-2HCL
Application:
16/921,684 →
Methods for Treating Cancer
Application:
16/580,914 →
Polymorphic Forms of RAD1901-2HCL
Application:
16/456,314 →
Polymorphic Forms of RAD1901-2HCL
Application:
15/863,850 →
Selective Androgen Receptor Modulators
Application:
14/806,360 →
Selective Androgen Receptor Modulators
Application:
13/876,809 →
Treatment of vasomotor symptoms with selective estrogen receptor modulators
Application:
12/308,640 →